Herceptin - can healthcare afford this expensive drug?
3rd Dec 2005, 00:19 GMT
New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug.
Herceptin - can healthcare afford this expensive drug? related news:
- Breast cancer drug may soon be available — HEALTH
- Chemo regimen can limit Herceptin heart risk-study (Reuters) — Yahoo! News: Health News
- Chemo regimen can limit Herceptin heart risk-study — Reuters: Health
- Genentech breast cancer drug looks even more promising — RSS Top Stories -- SiliconValley.com
- Breast Cancer Drug Looks More Promising (AP) — Yahoo! News: Health News
- Breast Cancer Drug Looks More Promising — ABC News: Health
- GlaxoSmithKline cancer drug threatens Herceptin market — Nature Biotechnology
- Its that christmas time again — starwars.com Blogs
- Using generics would slash drug costs — bizjournals.com Health Care:Health Insurance headlines
- Herceptin plus chemotherapy improves disease-free survival in early breast cancer — EurekAlert! - Cancer
Latest news from News-Medical News Feed:
- Children being set up for heart disease later on in life
- New cancer treatments use body's own immune system to kill melanoma tumours
- IVF success compromised by heavy smoking
- Why we all carry on with those bad habits
- Sugar and fizzy drinks linked to pancreatic cancer
- SpectraScience files new patent application
- Global Patient Safety Challenge: Clean Care is Safer Care
- FDA strengthens program for medical devices
- Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer
- More U.S residents trust TV for health info